Protagonist Therapeutics, Inc. (PTGX)
102.01
+1.13
(+1.12%)
USD |
NASDAQ |
May 21, 16:00
101.90
-0.11
(-0.11%)
After-Hours: 19:59
Protagonist Therapeutics Research and Development Expense (TTM) : 170.14M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 14.99B |
| AbbVie, Inc. | 9.501B |
| Insmed, Inc. | 828.00M |
| Madrigal Pharmaceuticals, Inc. | 451.53M |
| PTC Therapeutics, Inc. | 447.15M |